Resources

The latest in from biologics discovery and development through to production and supply chain management.

Oligonucleotides

The Growing Potential for Antisense Oligonucleotide Therapy

Antisense oligonucleotides hold major promise in future patient treatment approaches. Through targeting RNA to regulate protein expression, they can help to address diseases at their source and advance therapeutic outcomes.
Oligonucleotides

Targeted Delivery with FORCE: Novel Approaches in Oligo Therapeutics

How are oligo therapeutics revolutionising genetic disease treatments through precise targeting and transformative therapies? In this article, we explore how they provide precise gene expression interference for untreatable conditions by directly targeting disease-associated proteins and genetic mutations.
Oligonucleotides

Transforming Oligonucleotide Manufacturing: A Transformative UK Collaboration

A new collaboration from the Medicines Manufacturing Innovation Centre is looking to change the face of oligonucleotide development.
Oligonucleotides

Refractive Index Paves the Way to Greener Peptide and Oligonucleotide Synthesis

John Lopez of Novartis discusses the more sustainable possibilities refractive index monitoring offers in SPPS and SPOS.
Oligonucleotides

The Complex Case of Antisense Oligonucleotides

We gain a glimpse into what the landscape of antisense oligonucleotides looks like today, from computational representations to protein purification.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things biologics